Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Parasite Immunol ; 41(2): e12612, 2019 02.
Article in English | MEDLINE | ID: mdl-30578557

ABSTRACT

AIM: Acanthamoeba infections are characterized by an intense localized innate immune response associated with an influx of macrophages. Acanthamoeba protease production is known to affect virulence. Herein, the ability of Acanthamoeba trophozoite proteases, of either the laboratory Neff strain or a recently isolated clinical strain, to stimulate IL-12 and IL-6 and to activate protease-activated receptors, PAR1 and PAR2 expressed on murine macrophages, was investigated. METHOD AND RESULTS: Using selected protease inhibitors, leupeptin and E64, we showed that Acanthamoeba proteases can stimulate IL-12 and IL-6 by murine macrophages. Subsequently, using specific antagonists to inhibit PAR1 , and bone marrow-derived macrophages from PAR2 gene-deficient mice, we demonstrate that PAR1 , but not PAR2 contributes to macrophage IL-12 production in response to Acanthamoeba. In contrast, Acanthamoeba-induced IL-6 production is PAR1 and PAR2 independent. CONCLUSION: This study shows for the first time the involvement of PARs, expressed on macrophages, in the response to Acanthamoeba trophozoites and might provide useful insight into Acanthamoeba infections and their future treatments.


Subject(s)
Acanthamoeba/enzymology , Acanthamoeba/immunology , Amebiasis/immunology , Cell Cycle Proteins/metabolism , Macrophage Activation , Macrophages/immunology , Protein Serine-Threonine Kinases/metabolism , Receptor, PAR-2/metabolism , Animals , Immunity, Innate , Interleukin-12/metabolism , Male , Mice , Mice, Inbred BALB C , Peptide Hydrolases/metabolism , Signal Transduction
2.
Cornea ; 36(7): 785-790, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28486311

ABSTRACT

PURPOSE: To describe the diagnostic and clinical features and treatment results in 43 consecutive patients with microbiologically proven free-living amoebae (FLA) keratitis. METHODS: In this hospital-based, prospective case series, corneal scrapings from 43 patients with presumed amoebic keratitis were plated on nonnutrient agar. Amoebic isolates were identified morphologically and by the polymerase chain reaction. All patients with culture-proven FLA keratitis were treated with polyhexamethylene biguanide (PHMB) 0.02% eye drops. RESULTS: Forty-three corneal scrapings from 43 patients were found to be culture positive for FLA; 41 (95%) were from contact lens wearers and 2 (5%) were from noncontact lens wearers. Microscopic examination identified 4 Acanthamoeba spp, 24 Hartmannella spp, 12 vahlkampfiid amoebae, and 3 mixed infections with Hartmannella/vahlkampfiid amoebae. Morphological results were confirmed by the polymerase chain reaction. Patients with Acanthamoeba, Hartmannella, and vahlkampfiid keratitis had indistinguishable clinical features. In 38 eyes with keratitis at an early stage, treatment with PHMB 0.02% eye drops was fully successful. In 5 patients with advanced keratitis, topical PHMB 0.02% controlled the infection, but all of them developed a central corneal scar with visual deterioration. CONCLUSIONS: Acanthamoeba is not the only cause of amoebic keratitis, because this condition may also be caused by other FLA, such as Hartmannella and vahlkampfiid amoebae. This finding is epidemiologically interesting, suggesting a possible different geographical prevalence of the different FLA responsible for keratitis. Early diagnosis and proper antiamoebic treatment are crucial to yielding a cure.


Subject(s)
Acanthamoeba/isolation & purification , Amebiasis/diagnosis , Amoeba/isolation & purification , Eye Infections, Parasitic/diagnosis , Hartmannella/isolation & purification , Keratitis/diagnosis , Acanthamoeba/genetics , Amebiasis/drug therapy , Amebiasis/parasitology , Amoeba/genetics , Animals , Biguanides/therapeutic use , Cornea/parasitology , DNA Primers/chemistry , DNA, Protozoan/genetics , DNA, Ribosomal/genetics , Disinfectants/therapeutic use , Eye Infections, Parasitic/drug therapy , Eye Infections, Parasitic/parasitology , Female , Hartmannella/genetics , Humans , Keratitis/drug therapy , Keratitis/parasitology , Male , Ophthalmic Solutions , Polymerase Chain Reaction , Prospective Studies , RNA, Ribosomal, 18S/genetics
3.
Infect Immun ; 85(6)2017 06.
Article in English | MEDLINE | ID: mdl-28348053

ABSTRACT

Acanthamoeba castellanii is a ubiquitous free-living amoeba with a worldwide distribution that can occasionally infect humans, causing particularly severe infections in immunocompromised individuals. Dissecting the immunology of Acanthamoeba infections has been considered problematic due to the very low incidence of disease, despite the high exposure rates. While macrophages are acknowledged as playing a significant role in Acanthamoeba infections, little is known about how this facultative parasite influences macrophage activity. Therefore, in this study we investigated the effects of Acanthamoeba on the activation of resting macrophages. Consequently, murine bone marrow-derived macrophages were cocultured with trophozoites of either the laboratory Neff strain or a clinical isolate of A. castellaniiIn vitro real-time imaging demonstrated that trophozoites of both strains often established evanescent contact with macrophages. Both Acanthamoeba strains induced a proinflammatory macrophage phenotype characterized by the significant production of interleukin-12 (IL-12) and IL-6. However, macrophages cocultured with the clinical isolate of Acanthamoeba produced significantly less IL-12 and IL-6 than the Neff strain. The utilization of macrophages derived from MyD88-, TRIF-, Toll-like receptor 2 (TLR2)-, TLR4-, and TLR2/4-deficient mice indicated that Acanthamoeba-induced proinflammatory cytokine production was through MyD88-dependent, TRIF-independent, TLR4-induced events. This study shows for the first time the involvement of TLRs expressed on macrophages in the recognition of and response to Acanthamoeba trophozoites.


Subject(s)
Acanthamoeba castellanii/immunology , Interleukin-12/immunology , Interleukin-6/immunology , Macrophages/immunology , Myeloid Differentiation Factor 88/metabolism , Toll-Like Receptor 4/metabolism , Amebiasis/immunology , Animals , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , Signal Transduction/immunology , Toll-Like Receptor 4/genetics
4.
Infect Immun ; 84(10): 2953-62, 2016 10.
Article in English | MEDLINE | ID: mdl-27481240

ABSTRACT

Free-living amoebae of the genus Acanthamoeba can cause severe and chronic infections in humans, mainly localized in immune privileged sites, such as the brain and the eye. Monocytes/macrophages are thought to be involved in Acanthamoeba infections, but little is known about how these facultative parasites influence their functions. The aim of this work was to investigate the effects of Acanthamoeba on human monocytes/macrophages during the early phase of infection. Here, THP-1 cells, primary human monocytes isolated from peripheral blood, and human monocyte-derived macrophages were either coincubated with trophozoites of a clinical isolate of Acanthamoeba (genotype T4) or stimulated with amoeba-derived cell-free conditioned medium. Production of proinflammatory cytokines (tumor necrosis factor alpha [TNF-α], interleukin-6 [IL-6], and IL-12), anti-inflammatory cytokine (IL-10), and chemokine (IL-8) was evaluated at specific hours poststimulation (ranging from 1.5 h to 23 h). We showed that both Acanthamoeba trophozoites and soluble amoebic products induce an early anti-inflammatory monocyte-macrophage phenotype, characterized by significant production of IL-10; furthermore, challenge with either trophozoites or their soluble metabolites stimulate both proinflammatory cytokines and chemokine production, suggesting that this protozoan infection results from the early induction of coexisting, opposed immune responses. Results reported in this paper confirm that the production of proinflammatory cytokines and chemokines by monocytes and macrophages can play a role in the development of the inflammatory response during Acanthamoeba infections. Furthermore, we demonstrate for the first time that Acanthamoeba stimulates IL-10 production in human innate immune cells, which might both promote the immune evasion of Acanthamoeba and limit the induced inflammatory response.


Subject(s)
Acanthamoeba castellanii/immunology , Amebiasis/immunology , Cytokines/metabolism , Interleukin-10/metabolism , Leukocytes, Mononuclear/metabolism , Macrophages/metabolism , Analysis of Variance , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Genotype , Humans
5.
J Antimicrob Chemother ; 57(5): 891-8, 2006 May.
Article in English | MEDLINE | ID: mdl-16507561

ABSTRACT

OBJECTIVES: To evaluate the in vitro microbicidal activity against Acanthamoeba castellanii of a murine monoclonal anti-idiotypic antibody (KTmAb) and a synthetic killer mimotope (KP), which mimic a yeast killer toxin (KT) characterized by a wide spectrum of antimicrobial activity through interaction with specific cell wall receptors, mainly constituted by beta-glucans. METHODS: Amoebicidal activity was investigated after incubation of trophozoites under different experimental conditions with laminarinase, KTmAb, KP and a scrambled decapeptide (SP). To confirm the specific interaction of KP with beta-glucans, the experiments were also carried out in the presence of laminarin (beta1-3-glucan) or pustulan (beta1-6-glucan); both glucan molecules were co-incubated with KP or SP. RESULTS: KTmAb and KP exhibited a time-dependent killing activity, in comparison with SP or heat-inactivated KTmAb; this activity was completely abolished by pre-incubation with laminarin, but not by pustulan. Notably, in vitro amoebicidal activity was observed in the presence of laminarinase, an enzyme that specifically hydrolyses beta-glucans. Furthermore, KP specifically inhibited the growth of Acanthamoeba on infected contact lenses and the remaining adherent KP-treated trophozoites appeared strongly damaged. CONCLUSIONS: The results indicate that the expression of beta1-3-glucan receptors in the cell membrane is probably modulated during cell growth of A. castellanii and is critical for the killing activity of KT-like molecules. Our data confirm the broad antimicrobial spectra of KTmAb and KP, emphasize the crucial role of beta1-3-glucan in microbial physiology and suggest the potential use of KTmAb and KP in the prevention and therapy of Acanthamoeba infections or in preventing Acanthamoeba contamination during storage of contact lenses.


Subject(s)
Acanthamoeba castellanii/drug effects , Amebicides/pharmacology , Antibodies, Anti-Idiotypic/pharmacology , Antibodies, Monoclonal/pharmacology , Oligopeptides/pharmacology , Acanthamoeba castellanii/growth & development , Acanthamoeba castellanii/isolation & purification , Acanthamoeba castellanii/metabolism , Animals , Cell Wall/metabolism , Contact Lenses/microbiology , Glucans , Killer Factors, Yeast , Mice , Mycotoxins/pharmacology , Polysaccharides/pharmacology , beta-Glucans/metabolism
6.
Eur J Med Chem ; 39(2): 195-203, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14987828

ABSTRACT

A new series of 23 6,7-difluoro-3-methyl-2-phenylthio/phenylsulfonyl/phenylsulfinyl/benzylamino/phenylamino-quinoxaline 1,4-dioxides variously substituted in the phenyl moiety, was synthesized and submitted to in vitro evaluation for anti-mycobacterial, anti-trichomonas, anti-candida, anti-mycoplasma and antibacterial activities. In anti-mycobacterial assays, several compounds resulted active (MIC90 = 2.0-4.0 microg/ml) against Mycobacterium tuberculosis H37Rv. Anti-trichomonas screening showed a generally good activity of all compounds (MBC = 0.39-25.0 microg/ml) versus Trichomonas vaginalis, in particular the derivatives 5a,d, 7a, 9 and 11c ranged 0.39-0.78 microg/ml (metronidazole MBC = 12.5 microg/ml). Results of anti-candida assays showed that derivatives 7a, 8a,d and 9 were active against several species of Candida (C. albicans, C. krusei, C. parapsilosis and C. glabrata), having MIC50 between 3.9 and 31.25 microg/ml. The latter compounds were also submitted to anti-mycoplasma assay against Mycoplasma hominis, the results obtained showed that 7a, 8a,d and 9 inhibited the growth of the mycoplasma at the concentration of 0.1 mg/ml. In antibacterial tests only a few compounds showed an MIC50 lower than 62.5 microg/ml against representative strains of Gram-positive and Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Vibrio alginolyticus and Pseudomonas aeruginosa).


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Antitrichomonal Agents/pharmacology , Quinoxalines/chemical synthesis , Quinoxalines/pharmacology , Animals , Anti-Bacterial Agents/chemical synthesis , Antifungal Agents/chemical synthesis , Antitrichomonal Agents/chemical synthesis , Candida albicans/drug effects , Microbial Sensitivity Tests , Molecular Structure , Mycobacterium tuberculosis/drug effects , Parasitic Sensitivity Tests , Trichomonas vaginalis/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...